×

Lightning Round OT: Teva Pharma, Gushan and More

Teva Pharma : “Nice defensive name” for this tough market, Cramer said.

Gushan : This is a speculation play on the return of China, Cramer said. If you can stomach the risk, then buy Gushan.

Atlas Pipeline : Cramer’s bullish on APL. The stock’s been under pressure from hedge-fund selling, but the reduced stock price might offer investors a good opportunity to buy.







Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com